These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21053152)

  • 21. Confocal Bioluminescence Imaging for Living Tissues with a Caged Substrate of Luciferin.
    Hattori M; Kawamura G; Kojima R; Kamiya M; Urano Y; Ozawa T
    Anal Chem; 2016 Jun; 88(12):6231-8. PubMed ID: 27216493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoactivable bioluminescent probes for imaging luciferase activity.
    Shao Q; Jiang T; Ren G; Cheng Z; Xing B
    Chem Commun (Camb); 2009 Jul; (27):4028-30. PubMed ID: 19568622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioluminescence: imaging modality for in vitro and in vivo gene expression.
    Sadikot RT; Blackwell TS
    Methods Mol Biol; 2008; 477():383-94. PubMed ID: 19082962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for Doxorubicin delivery to colorectal cancer cells.
    Yan Y; Johnston AP; Dodds SJ; Kamphuis MM; Ferguson C; Parton RG; Nice EC; Heath JK; Caruso F
    ACS Nano; 2010 May; 4(5):2928-36. PubMed ID: 20420377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
    Dohmen C; Wagner E
    Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Firefly luciferase exhibits bimodal action depending on the luciferin chirality.
    Nakamura M; Maki S; Amano Y; Ohkita Y; Niwa K; Hirano T; Ohmiya Y; Niwa H
    Biochem Biophys Res Commun; 2005 Jun; 331(2):471-5. PubMed ID: 15850783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creation of artificial luciferases to expand their analytical potential.
    Frank LA
    Comb Chem High Throughput Screen; 2015; 18(10):919-29. PubMed ID: 26377544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioluminescent probe for hydrogen peroxide imaging in vitro and in vivo.
    Wu W; Li J; Chen L; Ma Z; Zhang W; Liu Z; Cheng Y; Du L; Li M
    Anal Chem; 2014 Oct; 86(19):9800-6. PubMed ID: 25192073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism.
    Luque-Ortega JR; Rivero-Lezcano OM; Croft SL; Rivas L
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1121-5. PubMed ID: 11257025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic factors that affect the intensity and stability of bioluminescence from firefly luciferase in living mammalian cells.
    Gandelman O; Allue I; Bowers K; Cobbold P
    J Biolumin Chemilumin; 1994; 9(6):363-71. PubMed ID: 7879652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery.
    Tang LY; Wang YC; Li Y; Du JZ; Wang J
    Bioconjug Chem; 2009 Jun; 20(6):1095-9. PubMed ID: 19438224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of TAT-mediated transport of detachable kinase substrates.
    Soughayer JS; Wang Y; Li H; Cheung SH; Rossi FM; Stanbridge EJ; Sims CE; Allbritton NL
    Biochemistry; 2004 Jul; 43(26):8528-40. PubMed ID: 15222764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
    Ofner CM; Pica K; Bowman BJ; Chen CS
    Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence.
    Wehrman TS; von Degenfeld G; Krutzik PO; Nolan GP; Blau HM
    Nat Methods; 2006 Apr; 3(4):295-301. PubMed ID: 16554835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvements in the application of firefly luciferase assays.
    Ford SR; Leach FR
    Methods Mol Biol; 1998; 102():3-20. PubMed ID: 9680605
    [No Abstract]   [Full Text] [Related]  

  • 36. Intracellular delivery of nanoparticles with CPPs.
    Sawant R; Torchilin V
    Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excited-state intermolecular proton transfer of the firefly's chromophore D-luciferin.
    Erez Y; Huppert D
    J Phys Chem A; 2010 Aug; 114(31):8075-82. PubMed ID: 20684579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ca(2+)-activator of the luminescence system of the earthworms Henlea sp., (Annelida: Clitellata: Oligochaeta: Enchytraeidae).
    Rodionova NS; Bondar VS; Petushkov VN
    Dokl Biochem Biophys; 2002; 386():260-3. PubMed ID: 12469504
    [No Abstract]   [Full Text] [Related]  

  • 39. An easily synthesized, photolyzable luciferase substrate for in vivo luciferase activity measurement.
    Yang J; Thomason DB
    Biotechniques; 1993 Nov; 15(5):848-50. PubMed ID: 8267979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of bioluminescence in a luciferin deficient form of the marine teleost, Porichthys, in response to exogenous luciferin.
    Barnes AT; Case JF; Tsuji FI
    Comp Biochem Physiol A Comp Physiol; 1973 Dec; 46(4):709-23. PubMed ID: 4148164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.